home / stock / bayzf / bayzf articles


BAYZF Articles, Bayer AG Registered Shares - From 01/11/24

Stock Information

Company Name: Bayer AG Registered Shares
Stock Symbol: BAYZF
Market: OTC

Menu

BAYZF BAYZF Quote BAYZF Short BAYZF News BAYZF Articles BAYZF Message Board
Get BAYZF Alerts

News, Short Squeeze, Breakout and More Instantly...

Large Drugmakers Show Enthusiasm To Embrace $100B Obesity Market, Despite Novo and Lilly's Dominance | Benzinga

Pharmaceutical companies, including Amgen Inc (NASDAQ: AMGN) and Pfizer Inc (NYSE: PFE), are strategically positionin...

Menopause Management: Bayer's Non-Hormonal Treatment Option Shows Efficacy In Trial | Benzinga

Monday, Bayer AG (OTC: BAYRY (OTC: BAYZF) announced topline results of Phase 3 studies OASIS 1 and 2 evaluating the efficacy an...

Bayer Study On Parkinson's Disease Gene Therapy Succeeds In Early-Stage Trial | Benzinga

Bayer AG (OTC:BAYRY) (OTC:BAYZF) and Asklepios BioPharmaceutical Inc completed an 18-month data collection in the Phase Ib trial for AB-1005 (AAV2...

Legal Victory For Bayer: Roundup Lawsuit Ends Five-Trial Losing Streak | Benzinga

In a significant turn of events, Bayer AG (OTC: BAYRY) (OTC: BAYZF) emerged victorious in a California lawsuit filed by Bruce Jones, who ...

Bayer Faces $3.5M Verdict in Fifth Consecutive Roundup Weedkiller Loss | Benzinga

Bayer AG (OTC: BAYRY) (OTC: BAYZF) encountered another setback in its ongoing legal battles related to its Roundup weedkiller after ...

Bayer Faces Growing Pressure Amid Roundup Lawsuits as Philadelphia Trial Nears Conclusion | Benzinga

The spotlight is on a Philadelphia trial as Bayer AG (OTC: BAYRY) (OTC: BAYZF) grapples with mounting legal challenges surrounding its Ro...

German Conglomerate Bayer Faces Investor Scrutiny Amid Unexpected Legal, Trial Setbacks | Benzinga

Bayer AG (OTC: BAYRY) (OTC: BAYZF) reportedly held an investor call to address concerns after intense scrutiny from investors following a seri...

Analyst Assess Implications of Bristol Myers' Investigational Blood Thinner Post Bayer Trial Setback Amid Shaken Investor Confidence | Benzinga

Monday, Bayer AG (OTC: BAYRY) (OTC: BAYZF) stopped the OCEANIC-AF Phase 3 study early after asundexian showed inferiority to&nb...

Bayer's Blood Thinner Study Stopped Early Due To Lack Of Efficacy: Details | Benzinga

Bayer AG (OTC: BAYRY) (OTC: BAYZF) stopped the OCEANIC-AF Phase 3 study investigating asundexian compared to apixaban (a direct oral...

Bayer's Legal Victory Against Merck: Delaware Court Rules In Company's Favor Regarding Talc Lawsuits | Benzinga

The Delaware Supreme Court reportedly ruled in favor of Bayer AG (OTC: BAYRY) (OTC: BAYZF), stating that the company is not accountable f...

Previous 10 Next 10